Bioinformatics & Artificial Intelligence
The collection of healthcare information is continuously increasing, generating vast amounts of heterogeneous and continuously flowing electronic data, commonly referred to as Health Big Data. These data are primarily derived from four main sources: (i) electronic health records (EHRs), (ii) medical imaging, (iii) experiments generated through omics technologies, and (iv) the so-called Internet of Things (IoT), which gathers information from a wide range of electronic devices, including smartphones, smartwatches, implantable medical devices, and wearable technologies.
Alongside technological advancements, two major fields of computer science have experienced remarkable growth in support of biomedical data analysis: Bioinformatics and Artificial Intelligence (AI).
Bioinformatics focuses on the organization, processing, and analysis of large-scale life science datasets, much of which is generated by omics platforms such as genomics, proteomics, and metabolomics. It enables the investigation of complex biological interactions through advanced computational and analytical tools.
Artificial Intelligence in medicine, on the other hand, makes it possible to interrogate heterogeneous and often unstructured data sources—including medical images, wearable device data, and biological experiments—and to develop robust predictive models using a data-driven approach. These methodologies support clinical research by improving diagnostic accuracy, predicting clinical outcomes, and identifying patients at higher risk, thereby enabling more personalized healthcare strategies.
With a strong problem-solving mindset, the Bioinformatics & Artificial Intelligence (BioAI) Facility at Centro Cardiologico Monzino has, over the years, supported basic, preclinical, and clinical research groups throughout all stages of the analytical workflow. This support ranges from experimental design and data management to inferential analyses and the development of advanced predictive models, with the ultimate goal of advancing precision medicine and accelerating translational research.
